Inactive Instrument

Other languages Zynex Inc. Other OTC

Equities

Zynex, Inc. Provides Earnings Guidance for the Second Quarter of 2024 and Reaffirms for the Full Year 2024	01/05
Zynex, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05
Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024	01/03
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.	01/03
Zynex, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	01/03
Zynex, Inc. authorizes a Buyback Plan.	29/02
Zynex, Inc. Introduces New Products	20/02
Zynex Receives US FDA Approval for Muscle Stimulation Device	06/02
Zynex, Inc. Receives FDA Clearance for its Next Generation NMES Device	06/02
Zynex Submits FDA Application for M-Wave Neuromuscular Electrical Stimulation Device	13/11
Zynex, Inc. Submits FDA Application for Its NMES Device	13/11
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.	01/11
Zynex, Inc. authorizes a Buyback Plan.	01/11
Zynex Board Initiates Review of Strategic Options Including Sale, Merger	31/23/31
Zynex Announces Review of Strategic Alternatives	31/23/31
Zynex, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27/23/27
Zynex, Inc. Provides Earnings Guidance for Fourth Quarter and Full Year of 2023	27/23/27
Sector Update: Health Care Stocks Gaining Late Afternoon	12/23/12
Sector Update: Health Care Stocks Higher Monday Afternoon	11/23/11
Zynex to Launch $10 Million Buyback Program	11/23/11

No results for this search